A new study led by researchers at Boston Children’s Hospital aims to determine whether monoclonal antibody Xolair (omalizumab) can stop or lessen the progression of asthma in high-risk children.
Over the last decade, pediatric medical devices have made up only about 25% of all healthcare devices approved by the FDA. The medical community is eager for change.
Immunization rates have decreased during the pandemic. Will we see a resurgence in infectious diseases as a result?
For now, legal battles surrounding the No Surprises Act have portions of the Act held up in court. What’s next?
- 1 of 257
- next ›